Skip to main content

Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib

Audiocasts - Original Research

Justin Arnall, PharmD, discusses the clinical significance of his research and case study on, “Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.”

Related Items
Comparison of Breakthrough Rates of Pneumocystis jirovecii Pneumonia in Adults With Malignancies Receiving Intravenous or Aerosolized Pentamidine for Prophylaxis
JHOP - April 2027 Vol 17, No 2 published on June 22, 2026 in Original Research, Adverse Events
Twice-Daily Bolus Versus Continuous Infusion Intravenous Tacrolimus for Prophylaxis of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem-Cell Transplant Recipients
JHOP - June 2027 Vol 17, No 3 published on June 17, 2026 in Original Research, Transplant, Infusion Issues, Adverse Events
Incidence of PARP Inhibitor Adverse Events Between Germline Versus Somatic Homologous Recombination Mutations
JHOP - December 2026 Vol 16, No 6 published on June 15, 2026 in Original Research, Adverse Events, PARP Inhibitors, Dose Escalation/Reduction
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy: The REMEDY Pilot Study
JHOP - August 2026 Vol 16, No 4 published on June 11, 2026 in Original Research, Chronic Myeloid Leukemia, Chemotherapy, Infections, Technology
Evaluation of Barriers to Initiating Chemotherapy for Pediatric Patients in the Inpatient Setting
JHOP - February 2027 Vol 17, No 1 published on June 11, 2026 in Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols
A Standardized Pharmacist-Guided Emesis Workflow: Implementation of Clinical Practice Guideline–Consistent Antiemetic Therapy in Children Undergoing Hematopoietic Stem Cell Transplantation
JHOP - October 2026 Vol 16, No 5 published on May 18, 2026 in Original Research, Adverse Events, Transplant, Drug Resistance, Oncology Pharmacy Programs/Protocols
CNS Prophylaxis in Patients With Diffuse Large B-Cell Lymphoma
JHOP - October 2026 Vol 16, No 5 published on May 12, 2026 in Original Research, Lymphoma, Methotrexate, Chemotherapy
Feasibility of Supplemental Materials Alongside Pharmacist-Led Chemotherapy Education: A Prospective Pilot Study
JHOP - August 2026 Vol 16, No 4 published on April 29, 2026 in Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols, Practical Issues in Pharmacy Management, Technology
Pharmacist-Led Management of Concomitant Medications in Oncology Trials: A Retrospective Analysis of Screening and Enrollment Outcomes
JHOP - February 2027 Vol 17, No 1 published on April 20, 2026 in Original Research, Clinical Trials, Drug–Drug Interaction
Impact of Pharmacist-Driven Oral Chemotherapy Treatment Plan Implementation on Monitoring and Supportive Care Interventions During CDK4/6 Inhibitor Therapy for Patients With Breast Cancer
JHOP - December 2026 Vol 16, No 6 published on April 20, 2026 in Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols, Supportive Care, Breast Cancer